EUVIMEDOdkrijte EUVIMED
Open access

Immunoreactive Microenvironment Modulator GBP5 Suppresses Ovarian Cancer Progression by Inducing Canonical Pyroptosis

Chang Zou, Jiacheng Shen, Fangfang Xu, Yingjun Ye, Yuanyuan Wu, Shaohua Xu

Journal of Cancer · 2024 · 15 (11) · 3510-3530

DOI: 10.7150/jca.94616 ↗

At a glance

Journal article in Journal of Cancer, 2024. Written by Chang Zou and 5 co-authors. Institution: Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity …. Cited 19 times so far (Crossref). The full text is freely available in PubMed Central.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Ovarian cancer has the highest mortality among gynecological malignancies, and exploring effective strategies to reverse the immunosuppressive tumor microenvironment in patients remains a pressing scientific challenge. In this study, we identified a pyroptosis-related protective factor, GBP5, which significantly inhibits the growth of ovarian cancer cells and patient-derived ovarian cancer organoids, impeding the invasion and migration of ovarian cancer cells. Results of immunohistochemistry and external single-cell data verification were consistent. Further research confirmed that GBP5 in ovarian cancer cell can induce canonical pyroptosis through JAK2/STAT1 pathway, thereby restraining the progression of ovarian cancer. Interestingly, in this study, we also discovered that ovarian cancer cells with high GBP5 expression exhibit increased expressions of CXCL9/10/11 in a co-culture assay. Subsequent immune cell infiltration analyses revealed the remodeling of immunosuppressive microenvironment in ovarian cancer patients, characterized by increased infiltration and polarization of M1 macrophages. External immunotherapy database analysis showed profound potential for the application of GBP5 in immunotherapy strategies for ovarian cancer. Overall, our study demonstrates that the protective factor GBP5 significantly inhibits ovarian cancer progression, triggering canonical pyroptosis through the JAK2-STAT1 pathway. Driven by its pro-inflammatory nature, it can also enhance M1 macrophages polarization and reverse immunosuppressive microenvironment, thus providing new insights for ovarian cancer treatment.

Subjects

Author keywords

GBP5JAK/STAT pathwaymacrophageovarian cancerpyroptosis

Authors and institutions

  • Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai 2…

Cite

APA

Zou, C., Shen, J., Xu, F., Ye, Y., Wu, Y., & Xu, S. (2024). Immunoreactive Microenvironment Modulator GBP5 Suppresses Ovarian Cancer Progression by Inducing Canonical Pyroptosis. Journal of Cancer, 15(11), 3510-3530. https://doi.org/10.7150/jca.94616

Vancouver

Zou C, Shen J, Xu F, Ye Y, Wu Y, Xu S. Immunoreactive Microenvironment Modulator GBP5 Suppresses Ovarian Cancer Progression by Inducing Canonical Pyroptosis. Journal of Cancer. 2024;15(11):3510-3530. doi:10.7150/jca.94616

BibTeX
@article{Zou2024,
  author = {Zou, Chang and Shen, Jiacheng and Xu, Fangfang and Ye, Yingjun and Wu, Yuanyuan and Xu, Shaohua},
  title = {Immunoreactive Microenvironment Modulator GBP5 Suppresses Ovarian Cancer Progression by Inducing Canonical Pyroptosis},
  journal = {Journal of Cancer},
  year = {2024},
  volume = {15},
  number = {11},
  pages = {3510--3530},
  doi = {10.7150/jca.94616}
}
Start for free →